Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
unlimited free pdf from europmc33217661    free
PDF from PMC    free
html from PMC    free
PDF vom PMID33217661  :  Publisher
PDF vom PMID33217661

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs #MMPMID33217661
  • Bhardwaj VK; Singh R; Das P; Purohit R
  • Comput Biol Med 2021[Jan]; 128 (ä): 104117 PMID33217661show ga
  • BACKGROUND: The main protease (Mpro) of SARS-CoV-2 is involved in the processing of vital polypeptides required for viral genome replication and transcription and is one of the best-characterized targets to inhibit the progression of SARS-CoV-2 in infected individuals. METHODS: We screened a set of novel classes of acridinediones molecules to efficiently bind and inhibit the activity of the SARS-CoV-2 by targeting the Mpro. The repurposed FDA-approved antivirals were taken as standard molecules for this study. Long term (1.1 mus) MD simulations were performed to analyze the conformational space of the binding pocket of Mpro bound to the selected molecules. RESULTS: The molecules DSPD-2 and DSPD-6 showed more favorable MM-PBSA interaction energies and were seated more deeply inside the binding pocket of Mpro than the topmost antiviral drug (Saquinavir). Moreover, DSPD-5 also exhibited comparable binding energy to Saquinavir. The analysis of per residue contribution energy and SASA studies indicated that the molecules showed efficient binding by targeting the S1 subsite of the Mpro binding pocket. CONCLUSION: The DSPD-2, DSPD-6, and DSPD-5 could be developed as potential inhibitors of SARS-CoV-2. Moreover, we suggest that targeting molecules to bind effectively to the S1 subsite could potentially increase the binding of molecules to the SARS-CoV-2 Mpro.
  • |*Coronavirus 3C Proteases/antagonists & inhibitors/chemistry[MESH]
  • |Antiviral Agents/*chemistry[MESH]
  • |Protease Inhibitors/*chemistry[MESH]
  • |SARS-CoV-2/*enzymology[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    104117 ä.128 2021